Albemarle CORP (ALB-PA) — SEC Filings

Q: What are the key financial highlights for Albemarle CORP?

Key financial highlights for Albemarle CORP are extracted from the most recent 10-K or 10-Q filings, including revenue, net income, EPS, debt-to-equity, cash position, and operating margin.

Q: Who are the key executives at Albemarle CORP?

Key executives at Albemarle CORP are identified from SEC filings including 10-K annual reports, proxy statements, and insider trade forms.

Q: What are the main risk factors for Albemarle CORP stock?

Risk factors for Albemarle CORP (ALB-PA) are assessed from SEC filings using AI analysis. Each filing is categorized as high, medium, or low risk based on disclosed risk factors and financial indicators.

Q: What are recent predictions and forward guidance from Albemarle CORP?

Forward-looking statements and predictions from Albemarle CORP are extracted from SEC filings including earnings reports, annual reports, and current event filings.

Latest SEC filings for Albemarle CORP. Recent 8-K filing on Dec 12, 2025. AI-decoded analysis of earnings, risk factors, and insider trades.

View Albemarle CORP on SEC EDGAR

Overview

Albemarle CORP (ALB-PA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Dec 12, 2025: Albemarle Corporation (ALB) announced on December 8, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and the election of new directors, alongside updates to compensatory plans for key executives.

Sentiment Summary

Across 31 filings, the sentiment breakdown is: 29 neutral, 2 mixed. The dominant filing sentiment for Albemarle CORP is neutral.

Filing Type Overview

Albemarle CORP (ALB-PA) has filed 11 8-K, 5 10-Q, 2 10-K/A, 1 DEF 14A, 2 10-K, 7 SC 13G/A, 2 SC 13G, 1 DEFA14A with the SEC between Jan 2024 to Dec 2025.

Filings by Year

2025 · 2024

Recent Filings (31)

Albemarle Corp. Announces Board and Executive Compensation Changes — 8-K · Dec 12, 2025 Risk: medium
Albemarle Corporation (ALB) announced on December 8, 2025, changes in its board of directors and executive compensation arrangements. The filing details the dep
Albemarle Narrows Losses Amid Lithium Price Headwinds — 10-Q · Nov 5, 2025 Risk: medium
Albemarle Corporation reported a significant net loss attributable to common shareholders of $202.38 million for the three months ended September 30, 2025, a su
Albemarle Corp Enters Material Agreement, Discloses Impairments — 8-K · Oct 27, 2025 Risk: medium
Albemarle Corporation (ALB) announced on October 23, 2025, that it entered into a material definitive agreement. The company also disclosed material impairments
Albemarle Corp: Board & Executive Changes Announced — 8-K · Aug 12, 2025 Risk: medium
Albemarle Corporation (ALB) announced on August 10, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the d
Albemarle Navigates Volatile Q2 with Strategic Lithium Focus — 10-Q · Aug 4, 2025 Risk: medium
Albemarle Corp (ALB-PA) reported a mixed second quarter for 2025, with revenue showing resilience but net income facing headwinds. The company's strategic outlo
Albemarle Corp Files 8-K on Financials — 8-K · Jul 30, 2025 Risk: low
Albemarle Corporation filed an 8-K on July 30, 2025, reporting on its results of operations and financial condition. The filing includes financial statements an
Albemarle Corp. Reports on Shareholder Votes — 8-K · May 9, 2025 Risk: low
Albemarle Corporation (ALB) filed an 8-K on May 9, 2025, reporting on matters submitted to a vote of security holders on May 6, 2025. The filing details the com
Albemarle Corp Files Q1 2025 10-Q — 10-Q · Apr 30, 2025 Risk: medium
Albemarle Corporation filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarte
Albemarle Corp. Files 2024 Annual Report Amendment — 10-K/A · Mar 31, 2025 Risk: low
Albemarle Corp. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. This filing, submitted on March 31, 2025, provides
Albemarle Corp Files 2024 Proxy Statement — DEF 14A · Mar 27, 2025 Risk: low
Albemarle Corp filed its DEF 14A on March 27, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2024. The
Albemarle Corp Files 2024 Annual Report — 10-K · Feb 12, 2025 Risk: low
Albemarle Corporation filed its annual report for the fiscal year ended December 31, 2024. The company is incorporated in Virginia and headquartered in Charlott
SC 13G/A Filing — SC 13G/A · Dec 5, 2024
SC 13G/A Filing — SC 13G/A · Nov 13, 2024
SC 13G Filing — SC 13G · Nov 13, 2024
SC 13G/A Filing — SC 13G/A · Nov 12, 2024
Albemarle Corp. Files Q3 2024 10-Q — 10-Q · Nov 6, 2024 Risk: medium
Albemarle Corp. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter
Albemarle Corp: Board Changes and Executive Compensation Update — 8-K · Oct 31, 2024 Risk: low
Albemarle Corporation (ALB) announced on October 28, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two n
SC 13G Filing — SC 13G · Oct 16, 2024
Albemarle Corp Elects New Directors, Discloses Officer Compensation — 8-K · Oct 7, 2024 Risk: low
Albemarle Corporation announced on October 7, 2024, a change in its Board of Directors, with the election of two new directors, Ms. Sarah E. Bates and Mr. Micha
SC 13G/A Filing — SC 13G/A · Sep 10, 2024
Albemarle Corp. Files Q2 2024 10-Q — 10-Q · Jul 31, 2024 Risk: medium
Albemarle Corp. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2
Albemarle Corp Files 8-K on Shareholder Votes & Bylaws — 8-K · May 10, 2024 Risk: low
Albemarle Corporation filed an 8-K on May 7, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing also includ
Albemarle Corp Files 8-K on Operations and Financials — 8-K · May 1, 2024 Risk: low
Albemarle Corporation filed an 8-K on May 1, 2024, reporting on its results of operations and financial condition, and providing financial statements and exhibi
Albemarle Corp. Files Amendment to Annual Report — 10-K/A · Mar 28, 2024 Risk: low
ALBEMARLE CORP (ALB-PA) filed a Amended Annual Report (10-K/A) with the SEC on March 28, 2024. Albemarle Corporation filed an amendment (No. 1) to its Form 10-K
Albemarle Corp Files Definitive Proxy Statement — DEFA14A · Mar 26, 2024 Risk: low
Albemarle Corporation (ALB) filed a DEFA14A, indicating it is a definitive proxy statement. This filing is related to the company's corporate governance and sha
Albemarle Corp Files 8-K on Material Agreements — 8-K · Mar 8, 2024 Risk: medium
Albemarle Corporation (ALB) filed an 8-K on March 8, 2024, reporting on events that occurred on March 5, 2024. The filing indicates a material definitive agreem
Albemarle Corp. Files 2023 Annual Report on Form 10-K — 10-K · Feb 15, 2024 Risk: medium
ALBEMARLE CORP (ALB-PA) filed a Annual Report (10-K) with the SEC on February 15, 2024. Albemarle Corporation filed its 2023 Form 10-K on February 15, 2024. The
Albemarle Files 8-K on Financial Results — 8-K · Feb 14, 2024 Risk: medium
Albemarle Corporation (ALB) filed an 8-K on February 14, 2024, reporting on its Results of Operations and Financial Condition, along with Financial Statements a
Vanguard Group Reports 12.87% Stake in Albemarle Corp — SC 13G/A · Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, for its holdings in Albemarle Corp. As of December 29, 2023, Vangua
Capital International Investors Amends Albemarle Corp. Stake — SC 13G/A · Feb 9, 2024 Risk: low
Capital International Investors, a Delaware-based investment firm, filed an amended SC 13G/A on February 9, 2024, indicating their ownership of Albemarle Corp.
BlackRock Amends Albemarle Stake, Files SC 13G/A on Dec 31 Holdings — SC 13G/A · Jan 25, 2024
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Albemarle Corporation's Common Stock as of December 31, 2023. This fil

Risk Profile

Risk Assessment: Of ALB-PA's 24 recent filings, 0 were flagged as high-risk, 11 as medium-risk, and 13 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Albemarle CORP's most recent 10-Q filing (Nov 5, 2025):

Revenue: $1.31B
Net Income: -$160.69M
EPS: -$1.72
Cash Position: $1.93B

Key Executives

John E. Smith
Sarah Lee
Masters Jr.
Luther K.issam IV
Pamela J. Craig
David J. Miller
Scott E. Tozier
Sarah E. Bates
Michael E. Sixt

Industry Context

Albemarle operates in the highly competitive lithium and bromine markets, essential components for electric vehicle batteries and various industrial applications. The industry is characterized by significant capital investment requirements, cyclical pricing, and increasing demand driven by the global energy transition. Competitors include other major lithium producers and emerging players, with ongoing consolidation and strategic partnerships shaping the landscape.

Top Tags

corporate-governance (4) · amendment (4) · Lithium (3) · Specialty Chemicals (3) · executive-compensation (3) · board-of-directors (3) · filing (3) · 10-Q (3) · financials (3) · institutional-ownership (3)

Key Numbers

Net Loss Attributable to Common Shareholders (Q3 2025): $202.38M — Significantly improved from $1.11B loss in Q3 2024
Net Sales (Q3 2025): $1.31B — Decreased from $1.35B in Q3 2024
Goodwill Impairment Charges (Q3 2025): $181.07M — New charge impacting profitability
Restructuring Charges (Q3 2025): $2.28M — Substantially down from $828.15M in Q3 2024
Cash and Cash Equivalents (Sept 30, 2025): $1.93B — Increased from $1.19B at Dec 31, 2024
Net Cash Provided by Operating Activities (Nine Months 2025): $893.78M — Strong cash generation from operations
Inventory Valuation Adjustments (Sept 30, 2025): $11.1M — Reduced from $104.0M at Dec 31, 2024 due to lithium pricing
Basic Loss Per Share (Q3 2025): $1.72 — Improved from $9.45 in Q3 2024
Current Liabilities: $X.XB — as of June 30, 2025, indicating operational adjustments
Period End Date: 2025-06-30 — the end of the reporting period for this 10-Q
Filing Date: 2025-08-04 — the date the 10-Q was filed with the SEC
SEC File Number: 001-12658 — Albemarle Corporation's SEC file number
IRS Employer Identification No.: 54-1692118 — Albemarle Corporation's EIN
Fiscal Year End: 2024 — The report covers the fiscal year ending December 31, 2024.
Commission file number: 001-12658 — Identifies the company's filings with the SEC

Forward-Looking Statements

{"claim":"Vanguard will maintain a significant stake in Albemarle Corp.","entity":"The Vanguard Group","targetDate":"Next 12 months","confidence":"high"}

Related Companies

ALB · SQM · LTHM · LAC · GFL

Frequently Asked Questions

What are the latest SEC filings for Albemarle CORP (ALB-PA)?

Albemarle CORP has 31 recent SEC filings from Jan 2024 to Dec 2025, including 11 8-K, 7 SC 13G/A, 5 10-Q. Each filing includes an AI-generated plain-English summary.

What is the overall sentiment of ALB-PA filings?

Across 31 filings, the sentiment breakdown is: 29 neutral, 2 mixed. The dominant sentiment is neutral.

Where can I find Albemarle CORP SEC filings explained simply?

ReadTheFiling provides AI-powered plain-English summaries of all Albemarle CORP (ALB-PA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.

What are the key financial highlights for Albemarle CORP?

Key financial highlights from Albemarle CORP's most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.

What is the investment thesis for ALB-PA?

The investment thesis for ALB-PA includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.

Who are the key executives at Albemarle CORP?

Key executives identified across Albemarle CORP's filings include John E. Smith, Sarah Lee, Masters Jr., Luther K.issam IV, Pamela J. Craig and 4 others.

What are the main risk factors for Albemarle CORP stock?

Of ALB-PA's 24 assessed filings, 0 were flagged high-risk, 11 medium-risk, and 13 low-risk.

What are recent predictions and forward guidance from Albemarle CORP?

Recent forward-looking statements from Albemarle CORP include guidance on {"claim":"Vanguard will maintain a significant stake in Albemarle Corp.","entity":"The Vanguard Group","targetDate":"Nex.